In a xenograft mouse model of multiple myeloma and BCL‐2, ABT‐263 exhibited increased toxicity when mice were treated with the BCL‐2, BCL‐XL, and BCL‐W inhibitor ABT‐263 (Tse et al., 2008). The gene discussed is BCL2; the disease is AL amyloidosis.